COVID-19 and bronchoscopy: Evidence from the field

  • Registration Closed


COVID-19 and bronchoscopy: Evidence from the field VIDEO (Cannot use Internet Explorer browser)
Open to view video.
Open to view video. COVID-19 and bronchoscopy: Evidence from the field

Not eligible for CE credit.

Bronchoscopy played an important role in identifying the virus responsible for the current COVID-19 pandemic, and there will be a continued need for bronchoscopy among critically ill COVID-19 patients and others with serious conditions. There is substantial evidence that bronchoscope reprocessing is not consistently effective. Inadequate reprocessing puts healthcare personnel and patients at risk of exposure to COVID-19 and other pathogens harbored in bronchoscopes. This webinar is designed to provide timely evidence to clinicians, infection preventionists, and reprocessing personnel who handle reusable bronchoscopes. The presenter is an epidemiologist who specializes in infection prevention. She explains key findings from her bronchoscope reprocessing studies and COVID-19 studies by others working in the field. This webinar also describes strategies for reducing bronchoscopy-associated risks that impact healthcare personnel and patient safety.


By the end of this short webinar, participants will be able to:

  1. Describe the role bronchoscopy plays in COVID-19
  2. Summarize recent research on bronchoscope reprocessing ineffectiveness
  3. Explain risks related to using bronchoscopes contaminated with COVID-19 or other pathogens
  4. Discuss strategies for reducing the risk of exposure to contaminated bronchoscopes

Content outline
  1. Evidence sparking concern about contaminated bronchoscopes
  2. Bronchoscope reprocessing effectiveness
  3. The need for universal precautions during COVID-19 outbreaks
  4. Strategies for reducing risk
  5. Sponsor acknowledgement (Supported by an educational grant from Ambu)

Cori L. Ofstead, MSPH

President & CEO, Ofstead & Associates

Cori Ofstead is an epidemiologist with 30 years of experience designing and conducting studies about the impact of clinical processes on patient outcomes. She has served as the Principal Investigator on numerous studies related to infection prevention, instrument processing, and vaccination against infectious diseases. Ms. Ofstead is nationally recognized for her groundbreaking research, and her studies have been published in peer-reviewed journals including CHEST, AJIC, ICHE, Urology, Journal of Hospital Infection, Endoscopy International Open, Journal of Wound Care, Gastroenterology Nursing, and Vaccine. She currently serves as a reviewer for AJIC, Endoscopy, and the Journal of Urology, and is an active member of the editorial board for AJIC. She has presented the findings of her studies at national and international conferences sponsored by the CDC, APIC, HSPA, AORN, SGNA, AGA, ASGE, and several universities. In addition, she currently serves as a preceptor for epidemiology students in the School of Public Health at the University of Minnesota.